Vinorelbine With or Without Thiotepa for HER2‐Negative Metastatic Breast Cancer: A Propensity Score Analysis

Vinorelbine With or Without Thiotepa for HER2‐Negative Metastatic Breast Cancer: A Propensity Score Analysis

ABSTRACT Background Vinorelbine is commonly used to treat metastatic breast cancer (mBC), while thiotepa is known for its ability to cross the blood–brain barrier. Methods Our retrospective study aimed to compare the efficacy and safety of vinorelbine with or without thiotepa in patients with HER2‐n...

Full description

Saved in:
Bibliographic Details
Main Authors: Aurelia Robert, Paul Gougis, Elise Dumas, Rebecca Loison, Victoire De Castelbajac, Marc Espie, Sylvie Giacchetti, Caroline Cuvier, Lamia Hassani, Johanna Wassermann, Luca Campedel, Marianne Veyri, Aurore Vozy, Jean Philippe Spano, Luis Teixeira, Baptiste Abbar
Format: Article
Language:English
Published: Wiley 2025-08-01
Series:Cancer Medicine
Subjects:
breast cancer
propensity score
real‐world evidence
thiotepa
vinorelbine
Online Access:https://doi.org/10.1002/cam4.71102
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/cam4.71102

Similar Items